Systematic review and meta-analysis of head-to-head trials comparing sulfonylureas and low hypoglycaemic risk antidiabetic drugs
Volke V, Katus U, Johannson A, et al.
BMC Endocr Disord. 2022;22(1):251.
Leggi
Trends in the association between diabetes and cardiovascular events, 1994-2019
Ke C, Lipscombe LL, Weisman A, et al.
JAMA. Pub. online 14 Oct 2022.
Leggi
Improving CGM uptake in underserved youth with type 1 diabetes: the IMPACT study
Lin T, Manfredo JA, Illesca N, et al.
Diabetes Technol Ther. Pub. online 12 Oct 2022.
Leggi
Myocardial extracellular volume expansion in type 2 diabetes is associated with ischemic heart disease, autonomic neuropathy, and active smoking
Boje AS, Sørensen MH, Gæde P, Madsen PL
Diabetes Care. 2022;dc220942.
Leggi
Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women
Mutie PM, Pomares-Milan H, Atabaki-Pasdar N, et al.
Diabetologia. Pub. online 12 Oct 2022.
Leggi
Statin use and risk of diabetes by subclinical atherosclerosis burden (from a multi-ethnic study of atherosclerosis report)
Rifai MA, Szklo M, Patel J, et al.
Am J Cardiol. 2022;S0002-9149(22)00958-4.
Leggi
AMD – SID | Sessioni di approfondimento
Carissimi Soci, siamo lieti di comunicare che la tradizionale collaborazione e partecipazione AMD - SID ai rispettivi Eventi Nazionali prosegue anche in occasione del 29° Congresso Nazionale 2022. L’appuntamento è come di consueto a Rimini dal 26 al 29 ottobre. Vi segnaliamo le sessioni di approfondimento scientifico ideate insieme: Giovedì…
Leggi
New strategies to improve clinical outcomes for diabetic kidney disease
Forst T, Mathieu C, Giorgino F, et al.
BMC Med. 2022;20(1):337.
Leggi
Characteristics and outcomes of patients with type 1 diabetes admitted with acute coronary syndromes
Nejatian MM, Lan NSR, Yeap BB, et al.
Diabetes Res Clin Pract. 2022;192:110093.
Leggi